alisporivir and Malaria

alisporivir has been researched along with Malaria* in 1 studies

Other Studies

1 other study(ies) available for alisporivir and Malaria

Article	Year
Targeting Artemisinin-Resistant Malaria by Repurposing the Anti-Hepatitis C Virus Drug Alisporivir. Antimicrobial agents and chemotherapy, 2022, 12-20, Volume: 66, Issue:12 The emergence of Plasmodium falciparum resistance raises an urgent need to find new antimalarial drugs. Here, we report the rational repurposing of the anti-hepatitis C virus drug, alisporivir, a nonimmunosuppressive analog of cyclosporin A, against artemisinin-resistant strains of P. falciparum. Topics: Antimalarials; Artemisinins; Cyclosporine; Drug Repositioning; Drug Resistance; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum	2022

Article

Year

Targeting Artemisinin-Resistant Malaria by Repurposing the Anti-Hepatitis C Virus Drug Alisporivir.

Antimicrobial agents and chemotherapy, 2022, 12-20, Volume: 66, Issue:12

The emergence of Plasmodium falciparum resistance raises an urgent need to find new antimalarial drugs. Here, we report the rational repurposing of the anti-hepatitis C virus drug, alisporivir, a nonimmunosuppressive analog of cyclosporin A, against artemisinin-resistant strains of P. falciparum.

Topics: Antimalarials; Artemisinins; Cyclosporine; Drug Repositioning; Drug Resistance; Humans; Malaria; Malaria, Falciparum; Plasmodium falciparum

2022